2018 Q1 Form 10-Q Financial Statement
#000114420418025756 Filed on May 07, 2018
Income Statement
| Concept | 2018 Q1 | 2017 Q1 |
|---|---|---|
| Revenue | $3.565M | $50.00M |
| YoY Change | -92.87% | |
| Cost Of Revenue | ||
| YoY Change | ||
| Gross Profit | ||
| YoY Change | ||
| Gross Profit Margin | ||
| Selling, General & Admin | $5.700M | $4.040M |
| YoY Change | 41.09% | 27.85% |
| % of Gross Profit | ||
| Research & Development | $14.54M | $10.57M |
| YoY Change | 37.57% | 30.17% |
| % of Gross Profit | ||
| Depreciation & Amortization | $168.0K | $31.92K |
| YoY Change | 426.38% | 71.98% |
| % of Gross Profit | ||
| Operating Expenses | $20.24M | $14.61M |
| YoY Change | 38.51% | 29.52% |
| Operating Profit | -$16.67M | -$13.93M |
| YoY Change | 19.69% | |
| Interest Expense | $420.0K | $0.00 |
| YoY Change | -100.0% | |
| % of Operating Profit | ||
| Other Income/Expense, Net | $423.0K | -$764.00 |
| YoY Change | -55466.49% | |
| Pretax Income | -$16.25M | -$13.93M |
| YoY Change | 16.65% | 26.75% |
| Income Tax | $0.00 | |
| % Of Pretax Income | ||
| Net Earnings | -$16.25M | -$13.93M |
| YoY Change | 16.64% | 26.78% |
| Net Earnings / Revenue | -455.79% | -27.86% |
| Basic Earnings Per Share | -$0.80 | |
| Diluted Earnings Per Share | -$0.80 | -$806.6K |
| COMMON SHARES | ||
| Basic Shares Outstanding | 17.27M shares | |
| Diluted Shares Outstanding | 20.23M |
Balance Sheet
| Concept | 2018 Q1 | 2017 Q1 |
|---|---|---|
| SHORT-TERM ASSETS | ||
| Cash & Short-Term Investments | $109.2M | $90.90M |
| YoY Change | 20.13% | 55.92% |
| Cash & Equivalents | $66.93M | $70.82M |
| Short-Term Investments | $42.20M | $20.10M |
| Other Short-Term Assets | $1.800M | $1.300M |
| YoY Change | 38.46% | 62.5% |
| Inventory | ||
| Prepaid Expenses | ||
| Receivables | $2.264M | |
| Other Receivables | $0.00 | |
| Total Short-Term Assets | $113.2M | $92.20M |
| YoY Change | 22.78% | 56.01% |
| LONG-TERM ASSETS | ||
| Property, Plant & Equipment | $700.0K | $200.0K |
| YoY Change | 250.0% | 100.0% |
| Goodwill | ||
| YoY Change | ||
| Intangibles | ||
| YoY Change | ||
| Long-Term Investments | $400.0K | $200.0K |
| YoY Change | 100.0% | -99.15% |
| Other Assets | ||
| YoY Change | ||
| Total Long-Term Assets | $42.80M | $42.10M |
| YoY Change | 1.66% | -35.63% |
| TOTAL ASSETS | ||
| Total Short-Term Assets | $113.2M | $92.20M |
| Total Long-Term Assets | $42.80M | $42.10M |
| Total Assets | $156.0M | $134.3M |
| YoY Change | 16.16% | 7.87% |
| SHORT-TERM LIABILITIES | ||
| YoY Change | ||
| Accounts Payable | $2.400M | $1.900M |
| YoY Change | 26.32% | -17.39% |
| Accrued Expenses | $4.600M | $4.000M |
| YoY Change | 15.0% | 233.33% |
| Deferred Revenue | ||
| YoY Change | ||
| Short-Term Debt | $0.00 | $0.00 |
| YoY Change | ||
| Long-Term Debt Due | ||
| YoY Change | ||
| Total Short-Term Liabilities | $12.20M | $11.00M |
| YoY Change | 10.91% | 205.56% |
| LONG-TERM LIABILITIES | ||
| Long-Term Debt | $0.00 | $0.00 |
| YoY Change | ||
| Other Long-Term Liabilities | $39.30M | $44.30M |
| YoY Change | -11.29% | |
| Total Long-Term Liabilities | $39.30M | $44.30M |
| YoY Change | -11.29% | |
| TOTAL LIABILITIES | ||
| Total Short-Term Liabilities | $12.20M | $11.00M |
| Total Long-Term Liabilities | $39.30M | $44.30M |
| Total Liabilities | $53.60M | $66.40M |
| YoY Change | -19.28% | 336.84% |
| SHAREHOLDERS EQUITY | ||
| Retained Earnings | ||
| YoY Change | ||
| Common Stock | ||
| YoY Change | ||
| Preferred Stock | ||
| YoY Change | ||
| Treasury Stock (at cost) | ||
| YoY Change | ||
| Treasury Stock Shares | ||
| Shareholders Equity | $102.4M | $67.90M |
| YoY Change | ||
| Total Liabilities & Shareholders Equity | $156.0M | $134.3M |
| YoY Change | 16.16% | 7.87% |
Cashflow Statement
| Concept | 2018 Q1 | 2017 Q1 |
|---|---|---|
| OPERATING ACTIVITIES | ||
| Net Income | -$16.25M | -$13.93M |
| YoY Change | 16.64% | 26.78% |
| Depreciation, Depletion And Amortization | $168.0K | $31.92K |
| YoY Change | 426.38% | 71.98% |
| Cash From Operating Activities | -$15.50M | $34.94M |
| YoY Change | -144.36% | -479.42% |
| INVESTING ACTIVITIES | ||
| Capital Expenditures | $39.00K | $0.00 |
| YoY Change | -100.0% | |
| Acquisitions | ||
| YoY Change | ||
| Other Investing Activities | -$1.060M | $6.660M |
| YoY Change | -115.92% | 166.4% |
| Cash From Investing Activities | -$1.100M | $6.658M |
| YoY Change | -116.52% | 166.32% |
| FINANCING ACTIVITIES | ||
| Cash Dividend Paid | ||
| YoY Change | ||
| Common Stock Issuance & Retirement, Net | ||
| YoY Change | ||
| Debt Paid & Issued, Net | ||
| YoY Change | ||
| Cash From Financing Activities | 1.494M | $640.0K |
| YoY Change | 133.43% | |
| NET CHANGE | ||
| Cash From Operating Activities | -15.50M | $34.94M |
| Cash From Investing Activities | -1.100M | $6.658M |
| Cash From Financing Activities | 1.494M | $640.0K |
| Net Change In Cash | -15.11M | $42.24M |
| YoY Change | -135.76% | -729.55% |
| FREE CASH FLOW | ||
| Cash From Operating Activities | -$15.50M | $34.94M |
| Capital Expenditures | $39.00K | $0.00 |
| Free Cash Flow | -$15.54M | $34.94M |
| YoY Change | -144.47% | -479.33% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2018Q1 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
2263556 | USD |
| CY2018Q1 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
20237209 | USD |
| CY2017Q1 | us-gaap |
Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
|
137248 | USD |
| CY2018Q1 | us-gaap |
License And Services Revenue
LicenseAndServicesRevenue
|
3565060 | USD |
| CY2018Q1 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-1491528 | USD |
| CY2017Q1 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-739261 | USD |
| CY2017Q1 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
14614198 | USD |
| CY2018Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-16248759 | USD |
| CY2017Q1 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
17268280 | shares |
| CY2017Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-13854501 | USD |
| CY2017Q1 | us-gaap |
Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
|
-137248 | USD |
| CY2018Q1 | us-gaap |
Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
|
-89975 | USD |
| CY2017Q1 | us-gaap |
Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
|
-61156 | USD |
| CY2018Q1 | us-gaap |
Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
|
23016 | USD |
| CY2017Q1 | us-gaap |
License And Services Revenue
LicenseAndServicesRevenue
|
684369 | USD |
| CY2018Q1 | us-gaap |
Depreciation
Depreciation
|
168086 | USD |
| CY2018Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
4082767 | USD |
| CY2018Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-15500822 | USD |
| CY2017Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
34944909 | USD |
| CY2018Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
1494431 | USD |
| CY2017Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
640017 | USD |
| CY2018Q1 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-15106579 | USD |
| CY2017Q1 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
42242926 | USD |
| CY2016Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
28575085 | USD |
| CY2017Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
70818011 | USD |
| CY2018Q1 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
248935 | USD |
| CY2017Q1 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-420948 | USD |
| CY2018Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
905666 | USD |
| CY2017Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
687497 | USD |
| CY2018Q1 | us-gaap |
Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
|
-86034 | USD |
| CY2017Q1 | us-gaap |
Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
|
13766 | USD |
| CY2018Q1 | us-gaap |
Available For Sale Securities Change In Net Unrealized Holding Gain Loss Net Of Tax
AvailableForSaleSecuritiesChangeInNetUnrealizedHoldingGainLossNetOfTax
|
-66959 | USD |
| CY2017Q1 | us-gaap |
Available For Sale Securities Change In Net Unrealized Holding Gain Loss Net Of Tax
AvailableForSaleSecuritiesChangeInNetUnrealizedHoldingGainLossNetOfTax
|
76092 | USD |
| CY2018Q1 | asmb |
Accrued Offering Cost Related To Issuance Of Common Stock
AccruedOfferingCostRelatedToIssuanceOfCommonStock
|
1494431 | USD |
| CY2017Q1 | asmb |
Accrued Offering Cost Related To Issuance Of Common Stock
AccruedOfferingCostRelatedToIssuanceOfCommonStock
|
640017 | USD |
| CY2018Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
39560 | USD |
| CY2017Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
0 | USD |
| CY2018Q1 | us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
11971000 | USD |
| CY2017Q1 | us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
6658000 | USD |
| CY2018Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-1100188 | USD |
| CY2017Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
6658000 | USD |
| CY2018Q1 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-1301504 | USD |
| CY2017Q1 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
49315631 | USD |
| CY2018Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-9865 | USD |
| CY2017Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
0 | USD |
| CY2018Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
4082767 | USD |
| CY2018Q1 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
1494431 | USD |
| CY2018Q1 | us-gaap |
Trading Securities Unrealized Holding Gain Loss
TradingSecuritiesUnrealizedHoldingGainLoss
|
-66959 | USD |
| CY2017Q1 | us-gaap |
Licenses Revenue
LicensesRevenue
|
50000000 | USD |
| CY2018Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
5093216 | shares |
| CY2017Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
4833035 | shares |
| CY2018Q1 | us-gaap |
Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
|
42487975 | USD |
| CY2018Q1 | us-gaap |
Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
|
4992 | USD |
| CY2018Q1 | us-gaap |
Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
|
260619 | USD |
| CY2018Q1 | us-gaap |
Available For Sale Securities
AvailableForSaleSecurities
|
42232348 | USD |
| CY2017Q4 | us-gaap |
Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
|
41450363 | USD |
| CY2017Q4 | us-gaap |
Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
|
5635 | USD |
| CY2017Q4 | us-gaap |
Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
|
194303 | USD |
| CY2018Q1 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
|
36406051 | USD |
| CY2018Q1 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
|
260619 | USD |
| CY2018Q1 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
|
36406051 | USD |
| CY2018Q1 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
|
260619 | USD |
| CY2018Q1 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
1313409 | USD |
| CY2017Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
1273849 | USD |
| CY2018Q1 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
581909 | USD |
| CY2017Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
413823 | USD |
| CY2018Q1 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
1307440 | USD |
| CY2017Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
4518128 | USD |
| CY2018Q1 | asmb |
Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
|
2310505 | USD |
| CY2017Q4 | asmb |
Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
|
674686 | USD |
| CY2018Q1 | asmb |
Accured General And Administrative Expenses Current
AccuredGeneralAndAdministrativeExpensesCurrent
|
1029527 | USD |
| CY2017Q4 | asmb |
Accured General And Administrative Expenses Current
AccuredGeneralAndAdministrativeExpensesCurrent
|
946186 | USD |
| CY2018Q1 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
1500000 | USD |
| CY2017Q2 | us-gaap |
Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
|
800000 | shares |
| CY2018Q1 | asmb |
Future Stock Based Compensation Expense Total
FutureStockBasedCompensationExpenseTotal
|
25547259 | USD |
| CY2018Q1 | us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
400000 | USD |
| CY2017Q1 | us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
300000 | USD |
| CY2017Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2018Q1 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
| CY2017Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
| CY2018Q1 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | shares |
| CY2018Q1 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
| CY2017Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
| CY2018Q1 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
| CY2018Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
| CY2017Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
| CY2018Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
50000000 | shares |
| CY2017Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
| CY2017Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
50000000 | shares |
| CY2018Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
20386736 | shares |
| CY2017Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
20137974 | shares |
| CY2017Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
20137974 | shares |
| CY2018Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
20386736 | shares |
| CY2018Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-16672149 | USD |
| CY2017Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-13929829 | USD |
| CY2018Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
423390 | USD |
| CY2017Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-764 | USD |
| CY2017Q1 | asmb |
Development Milestone Payments
DevelopmentMilestonePayments
|
630000000 | USD |
| CY2017Q1 | asmb |
Commercial Milestone Payments
CommercialMilestonePayments
|
2150000000 | USD |
| CY2018Q1 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 30.8pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <strong>Use of Estimates</strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 30.8pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The preparation of the condensed consolidated financial statements in conformity with the U.S. GAAP requires management to make estimates and assumptions that may affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of expenses during the reporting period. Actual results could differ from those estimates.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 29.7pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify">Significant estimates inherent in the preparation of the accompanying condensed consolidated financial statements include recoverability and useful lives (indefinite or finite) of intangible assets, assessment of impairment of goodwill, provisions for income taxes, timing of revenue recognition and allocation of the transaction price to performance obligations, and the fair value of stock options and warrants granted to employees, consultants, directors, investors, licensors, placement agents and underwriters.</div> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 29.7pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company’s estimates could be affected by external conditions, including those unique to the Company and general economic conditions. It is reasonably possible that these external factors could have an effect on the Company’s estimates and could cause actual results to differ from those estimates and assumptions.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
| CY2017Q1 | us-gaap |
Revenue Recognition Milestone Method Description
RevenueRecognitionMilestoneMethodDescription
|
the Company is eligible to receive variable consideration in the form of cost-sharing reimbursements, up to approximately $630 million in related to seven development milestones and up to approximately $2.15 billion in related to 12 commercial development and sales milestones in connection with the successful development and commercialization of licensed compounds for up to six different indications | |
| CY2018Q1 | asmb |
Future Stock Based Compensation Expense Current
FutureStockBasedCompensationExpenseCurrent
|
12899608 | USD |
| CY2018Q1 | asmb |
Future Stock Based Compensation Expense Year Two
FutureStockBasedCompensationExpenseYearTwo
|
8690702 | USD |
| CY2018Q1 | asmb |
Future Stock Based Compensation Expense Year Three
FutureStockBasedCompensationExpenseYearThree
|
3254762 | USD |
| CY2018Q1 | asmb |
Future Stock Based Compensation Expense Year Four
FutureStockBasedCompensationExpenseYearFour
|
676700 | USD |
| CY2018Q1 | asmb |
Futurestockbasedcompensationexpenseyearfive
Futurestockbasedcompensationexpenseyearfive
|
25487 | USD |
| CY2018Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
4082767 | USD |
| CY2017Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
1224647 | USD |
| CY2018Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P6Y8M12D | |
| CY2018Q1 | asmb |
Share Based Compensation Arrangement By Share Based Payment Award Options Non Vested In Period Fair Value1
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonVestedInPeriodFairValue1
|
10100000 | USD |
| CY2018Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
|
P9Y10M24D | |
| CY2018Q1 | asmb |
Deferred Revenueamortization Period Over Service Tenure
DeferredRevenueamortizationPeriodOverServiceTenure
|
P10Y | |
| CY2017Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.81 | |
| CY2018Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.80 | |
| CY2018Q1 | us-gaap |
Cost Of Reimbursable Expense
CostOfReimbursableExpense
|
200000 | USD |
